蒋勤, 孙常晟. 6-(4-取代苯基)-4,5-二氢-3(2H)-哒嗪酮类化合物的合成及其抑制血小板聚集的作用J. 药学学报, 1990, 25(8): 598-603.
引用本文: 蒋勤, 孙常晟. 6-(4-取代苯基)-4,5-二氢-3(2H)-哒嗪酮类化合物的合成及其抑制血小板聚集的作用J. 药学学报, 1990, 25(8): 598-603.
Q Jiang, CS Sun. SYNTHESIS AND PLATELET AGGREGATION INHIBITORY ACTIVITY OF 6-(4-SUBSTITUTED PHENYL)-4, 5-DIHYDRO -3(2H)-PYRIDAZINONESJ. Acta Pharmaceutica Sinica, 1990, 25(8): 598-603.
Citation: Q Jiang, CS Sun. SYNTHESIS AND PLATELET AGGREGATION INHIBITORY ACTIVITY OF 6-(4-SUBSTITUTED PHENYL)-4, 5-DIHYDRO -3(2H)-PYRIDAZINONESJ. Acta Pharmaceutica Sinica, 1990, 25(8): 598-603.

6-(4-取代苯基)-4,5-二氢-3(2H)-哒嗪酮类化合物的合成及其抑制血小板聚集的作用

SYNTHESIS AND PLATELET AGGREGATION INHIBITORY ACTIVITY OF 6-(4-SUBSTITUTED PHENYL)-4, 5-DIHYDRO -3(2H)-PYRIDAZINONES

  • 摘要: 为了寻找较理想的抗血栓药物,本文设计合成了6-(4-取代苯基)-4,5-二氢-3(2H)-哒嗪酮类化合物16个。对ADP诱导的大鼠体外血小板聚集,均有不同程度的抑制作用。其中,化合物Ⅱ2,Ⅱ3和Ⅱ4的作用大于CCI-17810,又以Ⅱ4的作用为最强。

     

    Abstract: To search for more ideal antithrombotic drugs sixteen 6-(4-substituted phenyl)-4, 5-dihydro-3(2H)-pyridazinones were designed and synthesized. Some. improvement of the synthetic method involved in constructing the piperazinyi group by cyclization of bisbromoethyl amine with 4-pyridazin0nyl anilines.Preliminary pharmacological tests showed that all of the target compounds inhibited ADP induced platelet aggregation. Compounds Ⅱ2, Ⅱ3 and Ⅱ4 were more potent than CCI-17810. The 5-methylderivative of CCI-17810 (Ⅱ4) was the most potent compound.

     

/

返回文章
返回